Customer speakers include AMD Senior Vice President CIO Hasmukh Ranjan; Dallas Cowboys Chief Information Officer Matt Messick; M&T Bank SVP Alex Pop and more along with Cisco partners and leaders...

Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced seven presentations on investigational ND0612 in Parkinson's disease (PD) will be shared at the 2024 International Congress of...

- Congruence's Revenir™ drug discovery engine identified diverse correctors of GCase designed to target the key biological dysfunction in Parkinson's disease patients with GBA1 mutations - -...

Mega Matrix Corp. ("MPU" or the "Company") (NYSE American: MPU), today announced that that its management attended APOS 2024 in Indonesia on September 25th. Hosted by Media Partners Asia in 2010,...

Data from the investigational Phase 1b RedirecTT-1 study demonstrate a safety profile consistent to TALVEY® and TECVAYLI® monotherapies RIO DE JANEIRO, Sept. 27, 2024 /PRNewswire/ -- Johnson &...

Updated data show 100 percent overall response rate with 56 percent of patients achieving complete response or better with weekly dosing, supporting the combinability of the GPRC5D bispecific antibody

Katrina E. Bell-Jordan, Ph.D. will be inaugurated Oct. 4. Celebratory activities to be held Oct. 3-5. CHICAGO, Sept. 27, 2024 /PRNewswire/ -- Northeastern Illinois University (NEIU) will celebrate...

RaySearch will be exhibiting its latest software innovations at ASTRO in Washington, D.C., September 29 – October 1. Participants can book demonstrations of RayStation®* treatment planning...

Shanghai Electric ("the Company") (SEHK:2727, SSE:601727) took the spotlight at the 24th China International Industry Fair (CIIF), one of the largest global platforms for industry players to...